BioSpace News Archive

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Veklury® (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19, under an exceptional approval pathway

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, will report unaudited financial results for the quarter ended March 31, 2020 after the market closes on Wednesday, May 13, 2020.

A patented surface-coating technology developed by Irish company Kastus® is shown to be effective against human coronavirus on treated surfaces, an independent Global testing laboratory has confirmed.

BetterLife Pharma Inc. announced that it has entered into an agreement to acquire worldwide rights to commercialize and sell AntiCovir, a potential COVID-19 treatment, from Altum Pharmaceuticals Inc. AntiCovir is an Interferon a2b based potential treatment that is proposed to be administered using a Metered Dose Inhaler or a nebulizer.

In an effort to further mitigate risk from the novel coronavirus to critical health-care workers and the community, a Kansas City-area health system has deployed Black & Veatch’s first portable Rapid Modular Health System (RaMHS) structure.

More than ever before, collaboration and efficiency are critical in scientific research as the world seeks solutions to the Coronavirus Pandemic. In recent weeks, pharma, financial and federal organizations made deliberate shifts, changing several facets of clinical trials to allow research to proceed at an unprecedented pace.

Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, and KenSci, a healthcare artificial intelligence (AI) platform company, announced today that a collaborative, foundational study on using machine learning (ML) to predict outcomes after shoulder arthroplasty has been published in Clinical Orthopaedics and Related Research, one of the premier scientific journals in orthopaedics.

The general meeting adopted the income statement and balance sheet for the company and for the group in accordance with submitted accounting documents.

Viracor Eurofins, Inc. (Viracor) a leading infectious disease testing laboratory for more than 35 years, announced the launch of its antibody assays for Coronavirus (COVID-19) SARS-CoV-2.

Apotex Corp. has reached a resolution with the U.S. Department of Justice (DOJ) Antitrust Division concerning the Department’s years long antitrust investigation into the U.S. generic drug industry.